Cargando…

Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**

The E6 oncoproteins of high-risk mucosal (hrm) human papillomaviruses (HPVs) contain a pocket that captures LxxLL motifs and a C-terminal motif that recruits PDZ domains, with both functions being crucial for HPV-induced oncogenesis. A chimeric protein was built by fusing a PDZ domain and an LxxLL m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Juan, Poirson, Juline, Foltz, Clémence, Chebaro, Yassmine, Schrapp, Maxime, Meyer, Amandine, Bonetta, Anaëlle, Forster, Anne, Jacob, Yves, Masson, Murielle, Deryckère, François, Travé, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512291/
https://www.ncbi.nlm.nih.gov/pubmed/26014966
http://dx.doi.org/10.1002/anie.201502646
_version_ 1782382473103015936
author Ramirez, Juan
Poirson, Juline
Foltz, Clémence
Chebaro, Yassmine
Schrapp, Maxime
Meyer, Amandine
Bonetta, Anaëlle
Forster, Anne
Jacob, Yves
Masson, Murielle
Deryckère, François
Travé, Gilles
author_facet Ramirez, Juan
Poirson, Juline
Foltz, Clémence
Chebaro, Yassmine
Schrapp, Maxime
Meyer, Amandine
Bonetta, Anaëlle
Forster, Anne
Jacob, Yves
Masson, Murielle
Deryckère, François
Travé, Gilles
author_sort Ramirez, Juan
collection PubMed
description The E6 oncoproteins of high-risk mucosal (hrm) human papillomaviruses (HPVs) contain a pocket that captures LxxLL motifs and a C-terminal motif that recruits PDZ domains, with both functions being crucial for HPV-induced oncogenesis. A chimeric protein was built by fusing a PDZ domain and an LxxLL motif, both known to bind E6. NMR spectroscopy, calorimetry and a mammalian protein complementation assay converged to show that the resulting PDZ-LxxLL chimera is a bivalent nanomolar ligand of E6, while its separated PDZ and LxxLL components are only micromolar binders. The chimera binds to all of the hrm-HPV E6 proteins tested but not to low-risk mucosal or cutaneous HPV E6. Adenovirus-mediated expression of the chimera specifically induces the death of HPV-positive cells, concomitant with increased levels of the tumour suppressor P53, its transcriptional target p21, and the apoptosis marker cleaved caspase 3. The bifunctional PDZ-LxxLL chimera opens new perspectives for the diagnosis and treatment of HPV-induced cancers.
format Online
Article
Text
id pubmed-4512291
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher WILEY-VCH Verlag
record_format MEDLINE/PubMed
spelling pubmed-45122912015-08-19 Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand** Ramirez, Juan Poirson, Juline Foltz, Clémence Chebaro, Yassmine Schrapp, Maxime Meyer, Amandine Bonetta, Anaëlle Forster, Anne Jacob, Yves Masson, Murielle Deryckère, François Travé, Gilles Angew Chem Int Ed Engl Communications The E6 oncoproteins of high-risk mucosal (hrm) human papillomaviruses (HPVs) contain a pocket that captures LxxLL motifs and a C-terminal motif that recruits PDZ domains, with both functions being crucial for HPV-induced oncogenesis. A chimeric protein was built by fusing a PDZ domain and an LxxLL motif, both known to bind E6. NMR spectroscopy, calorimetry and a mammalian protein complementation assay converged to show that the resulting PDZ-LxxLL chimera is a bivalent nanomolar ligand of E6, while its separated PDZ and LxxLL components are only micromolar binders. The chimera binds to all of the hrm-HPV E6 proteins tested but not to low-risk mucosal or cutaneous HPV E6. Adenovirus-mediated expression of the chimera specifically induces the death of HPV-positive cells, concomitant with increased levels of the tumour suppressor P53, its transcriptional target p21, and the apoptosis marker cleaved caspase 3. The bifunctional PDZ-LxxLL chimera opens new perspectives for the diagnosis and treatment of HPV-induced cancers. WILEY-VCH Verlag 2015-06-26 2015-05-26 /pmc/articles/PMC4512291/ /pubmed/26014966 http://dx.doi.org/10.1002/anie.201502646 Text en © 2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/4.0/ © 2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Communications
Ramirez, Juan
Poirson, Juline
Foltz, Clémence
Chebaro, Yassmine
Schrapp, Maxime
Meyer, Amandine
Bonetta, Anaëlle
Forster, Anne
Jacob, Yves
Masson, Murielle
Deryckère, François
Travé, Gilles
Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
title Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
title_full Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
title_fullStr Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
title_full_unstemmed Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
title_short Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand**
title_sort targeting the two oncogenic functional sites of the hpv e6 oncoprotein with a high-affinity bivalent ligand**
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512291/
https://www.ncbi.nlm.nih.gov/pubmed/26014966
http://dx.doi.org/10.1002/anie.201502646
work_keys_str_mv AT ramirezjuan targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT poirsonjuline targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT foltzclemence targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT chebaroyassmine targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT schrappmaxime targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT meyeramandine targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT bonettaanaelle targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT forsteranne targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT jacobyves targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT massonmurielle targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT deryckerefrancois targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand
AT travegilles targetingthetwooncogenicfunctionalsitesofthehpve6oncoproteinwithahighaffinitybivalentligand